Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Correction: Selective Blockade of CD28-Mediated T Cell Costimulation Protects Rhesus Monkeys against Acute Fatal Experimental Autoimmune Encephalomyelitis.
Aging with multiple sclerosis: cognitive, emotional and neuropathological considerations.
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
Combinatorial Effect of Metformin and Lovastatin Impedes T-cell Autoimmunity and Neurodegeneration in Experimental Autoimmune Encephalomyelitis.
Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.
Use of altered informed consent in pragmatic clinical research.
Roche hits multiple sclerosis landmarks.
Caffeine treatment aggravates secondary degeneration after spinal cord injury.
The genetics of Charcot-Marie-Tooth disease: current trends and future implications for diagnosis and management.
Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases.
Outcomes After Early Administration of Plasma Exchange in Pediatric Central Nervous System Inflammatory Demyelination.
Optic neuritis as first clinical manifestations the multiple sclerosis.
Evaluating the Effects of White Matter Multiple Sclerosis Lesions on the Volume Estimation of 6 Brain Tissue Segmentation Methods.
Clinical applications at ultrahigh field (7 T). Where does it make the difference?
Progress and Roadblocks Along the Pathway to Multiple Sclerosis Treatment.
Contribution of the cerebellum to cognitive performance in children and adolescents with multiple sclerosis.
Evaluation of Lovastatin Effects on Expression of Anti-apoptotic Nrf2 and PGC-1α Genes in Neural Stem Cells Treated with Hydrogen Peroxide.
The Stress-Buffering Effects of Hope on Adjustment to Multiple Sclerosis.
Label-free imaging to study phenotypic behavioural traits of cells in complex co-cultures.
Abnormal galactosylation of immunoglobulin G in cerebrospinal fluid of multiple sclerosis patients.
Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel.
White Matter Injury in Ischemic Stroke.
[Semaphorin 4 in multiple sclerosis].
IL-1β Is Involved with the Generation of Pain in Experimental Autoimmune Encephalomyelitis.
Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.
Pages
« first
‹ previous
…
655
656
657
658
659
660
661
662
663
…
next ›
last »